Eric Padron
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Virus-based gene therapy research
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 277
- Acute Myeloid Leukemia Research 259
- Chronic Myeloid Leukemia Treatments 57
- Genetics 161
- Myeloproliferative Neoplasms: Diagnosis and Treatment 113
- Chronic Lymphocytic Leukemia Research 48
- Hemoglobinopathies and Related Disorders 16
- Co-authors
- Rami S. Komrokji (251 shared papers)Alan F. List (157 shared papers)Jeffrey E. Lancet (212 shared papers)David A. Sallman (181 shared papers)Najla Al Ali (93 shared papers)Najla H. Al Ali (59 shared papers)Mavis Agbandje‐McKenna (6 shared papers)Robert McKenna (6 shared papers)
- Journals
- Blood (160 papers)Leukemia Research (15 papers)Leukemia (13 papers)American Journal of Hematology (9 papers)Journal of Clinical Oncology (6 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Eric Padron
303 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 102
- Hematology 2.8k
- Genetics 1.5k
- Genetics 619
- Molecular Biology 1.5k
- Immunology 430
Countries citing papers authored by Eric Padron
This map shows the geographic impact of Eric Padron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Padron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Padron more than expected).
Fields of papers citing papers by Eric Padron
This network shows the impact of papers produced by Eric Padron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Padron. The network helps show where Eric Padron may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Padron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 343 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 270 | |
| 2 | 2016 | 213 | |
| 3 | 2007 | 211 | |
| 4 | 2006 | 169 | |
| 5 | 2013 | 150 | |
| 6 | 2015 | 142 | |
| 7 | 2013 | 112 | |
| 8 | 2017 | 98 | |
| 9 | 2016 | 96 | |
| 10 | 2005 | 89 | |
| 11 | 2014 | 82 | |
| 12 | 2020 | 78 | |
| 13 | 2018 | 68 | |
| 14 | 2016 | 67 | |
| 15 | 2019 | 63 | |
| 16 | 2012 | 58 | |
| 17 | 2018 | 52 | |
| 18 | 2021 | 50 | |
| 19 | 2015 | 50 | |
| 20 | 2013 | 49 |
About Eric Padron
Eric Padron is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Immunology, having authored 343 papers that have together received 4.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (259 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (113 papers), Chronic Myeloid Leukemia Treatments (57 papers), Chronic Lymphocytic Leukemia Research (48 papers), Cancer Genomics and Diagnostics (21 papers), Lymphoma Diagnosis and Treatment (20 papers), Acute Lymphoblastic Leukemia research (18 papers) and Hemoglobinopathies and Related Disorders (16 papers). The work is most often cited by research in Hematology (2.8k citations), Genetics (1.5k citations), Genetics (619 citations), Molecular Biology (1.5k citations) and Immunology (430 citations). Eric Padron has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Rami S. Komrokji, Alan F. List, Jeffrey E. Lancet, David A. Sallman, Najla Al Ali, Najla H. Al Ali, Mavis Agbandje‐McKenna, Robert McKenna, Kendra Sweet and Nicholas Muzyczka. Their work appears in journals such as Blood, Leukemia Research, Leukemia, American Journal of Hematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.